Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitors
OwnerCraig Anderson, Salim Yusuf +2inventors
InventorsCraig Anderson, Salim Yusuf, Peter Sleight, Lutz Hilbrich
Life of this patent
Estimating the term…
Abstract
The invention relates to a method of treatment of dementia and/or regression of cognitive function, comprising co-administration of effective amounts of an Angiotensin II antagonist and an Angiotensin I Converting Enzyme inhibitor, pharmaceutical compositions containing an Angiotensin II antagonist together with an ACE inhibitor and the use of an Angiotensin II antagonist and an ACE inhibitor for the manufacture of corresponding pharmaceutical compositions.
Claims10
A method of treatment of dementia and/or regression of cognitive function, comprising the co-administration of effective amounts of an ANG II antagonist and an ACE inhibitor to a person in need of such treatment.
Pharmaceutical composition for the treatment of the human or non-human mammalian body for treating dementia and/or regression of cognitive function comprising telmisartan as ANG II antagonist in an amount of 40 mg to 80 mg and ramipril as ACE inhibitor in an amount of 2.5 mg to 10 mg in single dosage units for simultaneous, separate or sequential use in treatment of said indications, optionally together with one or more pharmaceutically acceptable diluents and/or carriers.
Dependencies are inferred from the claim text.